ImmunityBio, Inc. IBRX Weighted-Average Discount Rate
Weighted-Average Discount Rate at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s weighted-average discount rate.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s weighted-average discount rate?
- ImmunityBio, Inc. (IBRX) reported weighted-average discount rate of 11.6% in Q1 2026.
- What is the long-term trend for ImmunityBio, Inc.'s weighted-average discount rate?
- Over 3 years (2022 to 2025), ImmunityBio, Inc.'s weighted-average discount rate has grown at a -0.3% compound annual growth rate (CAGR), from 11.7% to 11.6%.
- What does weighted-average discount rate mean?
- This represents the average interest rate used to calculate the present value of the company's lease liabilities. It reflects the company's incremental borrowing rate or the rate implicit in the leases. This metric is essential for understanding the cost of capital embedded in the company's off-balance-sheet financing arrangements.